Answers are grounded in this paper and cite their sources.
A number of ways and means have evolved to provide resistance to eubacteria challenged by beta-lactams. This review is focused on pathogens that resist by expressing low-affinity targets for these antibiotics, the penicillin-binding proteins (PBPs). Even within this narrow focus, a great variety of strategies have been uncovered such as the acquisition of an additional low-affinity PBP, the overexpression of an endogenous low-affinity PBP, the alteration of endogenous PBPs by point mutations or homologous recombination or a combination of the above.
No takes yet. Share an insight, caveat, or question.
Zapun et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: